Cidara Therapeutics and WuXi XDC Expand Collaboration for IND-enabling CMC Development to Advance Cidara’s CD73 Oncology DFC Program
Cidara Therapeutics, Inc.Agreement builds upon the existing relationship with WuXi XDC for CMC development and GMP manufacturing of Cidara’s CD388 ...
Read more